CWM
CL icon

Concentric Wealth Management’s Colgate-Palmolive CL Stock Holding History

Concentric Wealth Management’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.7M Sell
16,415
-75
-0.5% -$7.64K 0.42% 63
2024
Q2 		$1.6M Sell
16,490
-151
-0.9% -$13.9K 0.42% 63
2024
Q1 		$1.5M Buy
16,641
+76
+0.5% +$6.44K 0.4% 64
2023
Q4 		$1.32M Sell
16,565
-920
-5% -$69.2K 0.38% 67
2023
Q3 		$1.24M Hold
17,485
– – 0.41% 67
2023
Q2 		$1.35M Sell
17,485
-160
-0.9% -$12.4K 0.43% 65
2023
Q1 		$1.33M Sell
17,645
-200
-1% -$14.9K 0.44% 64
2022
Q4 		$1.41M Sell
17,845
-1,092
-6% -$81.9K 0.48% 63
2022
Q3 		$1.33M Sell
18,937
-50
-0.3% -$3.92K 0.49% 66
2022
Q2 		$1.52M Sell
18,987
-520
-3% -$40.7K 0.51% 65
2022
Q1 		$1.48M Sell
19,507
-20
-0.1% -$1.58K 0.43% 70
2021
Q4 		$1.67M Sell
19,527
-250
-1% -$19.5K 0.47% 68
2021
Q3 		$1.5M Hold
19,777
– – 0.46% 67
2021
Q2 		$1.61M Hold
19,777
– – 0.49% 68
2021
Q1 		$1.56M Sell
19,777
-376
-2% -$29.5K 0.51% 66
2020
Q4 		$1.72M Sell
20,153
-250
-1% -$20.7K 0.63% 62
2020
Q3 		$1.57M Buy
20,403
+112
+0.6% +$8.54K 0.68% 58
2020
Q2 		$1.49M Sell
20,291
-1,755
-8% -$125K 0.7% 57
2020
Q1 		$1.46M Sell
22,046
-1,831
-8% -$129K 0.81% 51
2019
Q4 		$1.64M Buy
23,877
+15,822
+196% +$1.08M 0.7% 56
2019
Q3 		$592K Sell
8,055
-71
-0.9% -$5.15K 0.38% 63
2019
Q2 		$582K Buy
8,126
+3
+0% +$213 0.38% 63
2019
Q1 		$557K Sell
8,123
-396
-5% -$25.6K 0.38% 61
2018
Q4 		$507K Buy
8,519
+5
+0.1% +$313 0.39% 62
2018
Q3 		$570K Buy
8,514
+4
+0% +$266 0.4% 64
2018
Q2 		$552K Buy
8,510
+4
+0% +$262 0.4% 65
2018
Q1 		$610K Buy
8,506
+3
+0% +$216 0.45% 60
2017
Q4 		$642K Buy
8,503
+3
+0% +$219 0.46% 60
2017
Q3 		$619K Buy
8,500
+4
+0% +$288 0.47% 63
2017
Q2 		$630K Buy
8,496
+3
+0% +$223 0.5% 60
2017
Q1 		$622K Sell
8,493
-46
-0.5% -$3.22K 0.51% 59
2016
Q4 		$559K Buy
+8,539
New +$585K 0.47% 62

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Concentric Wealth Management's CL Position: Q3 2024 in Review

Concentric Wealth Management reduced its Colgate-Palmolive (CL) stake by 0.45% in Q3 2024, selling an estimated $7.64K and leaving 16,415 shares worth $1.7M. The position accounts for 0.42% of the portfolio, ranked #63.

Concentric Wealth Management first reported a position in CL in Q4 2016 and has held it in 32 quarters since. The position peaked at $1.72M in Q4 2020. 1,909 funds tracked by Wall St. Rank hold CL as of Q3 2024.

  • Concentric Wealth Management held 16,415 shares of Colgate-Palmolive worth $1.7M as of Q3 2024.
  • Concentric Wealth Management sold 75 Colgate-Palmolive shares in Q3 2024, an estimated $7.64K.
  • Colgate-Palmolive made up 0.42% of Concentric Wealth Management's portfolio in Q3 2024, its #63 holding.
  • Concentric Wealth Management first reported a position in Colgate-Palmolive in Q4 2016 and has held it in 32 quarters since.
  • Concentric Wealth Management's Colgate-Palmolive position peaked at $1.72M in Q4 2020.
  • 1,909 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2024.

Based on Concentric Wealth Management's 13F filing for Q3 2024, filed 13 Nov 2024.